NPI: 1598016305 · SPRINGFIELD, MO 65803 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/20/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/20/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,188 | $99K |
| 2019 | 3,958 | $84K |
| 2020 | 1,402 | $46K |
| 2021 | 1,861 | $98K |
| 2022 | 686 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 9,707 | 655 | $366K |
| 85041 | 206 | 184 | $0.00 | |
| 83970 | 140 | 125 | $0.00 | |
| 83540 | 120 | 111 | $0.00 | |
| 85048 | 204 | 182 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 128 | 111 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,298 | 88 | $0.00 |
| 83550 | 120 | 111 | $0.00 | |
| 82728 | 100 | 93 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 59 | 37 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 13 | 12 | $0.00 |